Today: 20 March 2026
Subscribe
Browse Category

NYSE:MCK 24 September 2025 - 6 February 2026

McKesson stock falls today after 16% earnings surge as traders reassess guidance and spinoff clock (MCK)

McKesson stock falls today after 16% earnings surge as traders reassess guidance and spinoff clock (MCK)

McKesson shares fell 2.1% to $937.31 Friday, retreating after a 16.5% surge on an upgraded 2026 profit forecast and plans to spin off its medical-surgical division. Quarterly revenue rose 11% to $106.2 billion, with adjusted EPS up 16% to $9.34. The company filed an automatic shelf registration for future securities sales. TD Cowen raised its price target to $1,012, citing strong oncology and prescription-tech results.
6 February 2026
··
Cardinal Health stock jumps 9% after earnings beat — what CAH investors watch next

Cardinal Health stock jumps 9% after earnings beat — what CAH investors watch next

Cardinal Health shares jumped 9% to $226.05 Thursday after the company raised its fiscal 2026 adjusted earnings forecast to $10.15-$10.35 per share. Quarterly revenue rose 19% and adjusted profit beat estimates, driven by strong specialty drug demand. CEO Jason Hollar cited double-digit profit growth across all segments. Specialty medicines, including GLP-1 drugs, contributed significantly to revenue gains.
5 February 2026
····
McKesson Stock (MCK) After-Hours Update for Dec. 24, 2025: Today’s News, Analyst Forecasts, and What to Watch Before the Market Reopens Dec. 26

McKesson Stock (MCK) After-Hours Update for Dec. 24, 2025: Today’s News, Analyst Forecasts, and What to Watch Before the Market Reopens Dec. 26

McKesson closed at $826.43 on Dec. 24, up 0.09% in light pre-holiday trading; after-hours quotes slipped to around $825.50 on low volume. Trading was muted due to the early market close and thin liquidity. The stock remains below its 52-week high of $895.58. Zacks reiterated a Hold rating, highlighting strong earnings and revenue estimates for the current and next fiscal years.
25 December 2025
·
Shops Open on Christmas Day 2025 in Canada: What’s Open, What’s Closed, and Where to Find Essentials

Shops Open on Christmas Day 2025 in Canada: What’s Open, What’s Closed, and Where to Find Essentials

Most major retailers, malls, and grocery stores in Canada close on Christmas Day. Convenience stores, gas stations, and some pharmacies, such as 7-Eleven and select Shoppers Drug Mart or Rexall locations, remain open, often with reduced hours. Movie theatres and some tourist attractions also operate. Shoppers are advised to check local hours before heading out.
25 December 2025
······
McKesson Corporation (MCK) Stock Today: Price Drop, Oncology Push and 2026 Outlook as of December 3, 2025

McKesson Corporation (MCK) Stock Today: Price Drop, Oncology Push and 2026 Outlook as of December 3, 2025

McKesson shares closed at $805.37 on December 3, down 2.93% and about 10% below their 52-week high near $895. The drop follows profit-taking, portfolio moves, and investor reaction to new guidance and a planned Med-Surg spin-off. Despite the decline, the stock remains up over 30% for the year. Analysts maintain bullish ratings, with price targets above current levels.
4 December 2025
·
McKesson (MCK) Stock Near Record High as Big Money Moves In – Latest News and Outlook on November 29, 2025

McKesson (MCK) Stock Near Record High as Big Money Moves In – Latest News and Outlook on November 29, 2025

McKesson closed at $879 on November 28, just below its record high, with a market cap near $109 billion and a P/E ratio around 35. Quadrature Capital opened a $37.7 million position, joining other institutional investors increasing stakes. The stock has surged nearly 60% from its 52-week low. Analyst sentiment remains mixed despite recent earnings beats and strong trading volume.
30 November 2025
·
NYSE Rollercoaster: Fed Caution Halts Tech Rally, Mega-Deals & Gold Spike in Wild 48 Hours

NYSE Rollercoaster: Fed Caution Halts Tech Rally, Mega-Deals & Gold Spike in Wild 48 Hours

Wall Street’s AI-fueled rally stalled Sept. 23 as the Nasdaq fell 0.95% and S&P 500 dropped 0.6% after Fed Chair Jerome Powell warned on rates and valuations. Tech stocks led declines, with Nvidia down 3% and Oracle off 4%. Gold hit a record near $3,764/oz as investors sought safety. Micron jumped 3% after strong earnings and an upbeat AI outlook.
24 September 2025
·················

Stock Market Today

  • Regeneus Ltd (RGS.AX) Jumps 33% on Heavy Volume, Signals Short-Term Upside
    March 19, 2026, 10:42 PM EDT. Regeneus Ltd (RGS.AX) surged 33.33% to A$0.012 on March 20, 2026, driven by unusually heavy volume of 4.28 million shares, nearly seven times the average. The stock broke above its 50-day and 200-day moving averages, indicating increased short-term trader interest in this clinical-stage biotech focused on osteoarthritis and wound healing. Despite negative earnings per share and liquidity constraints, the price action reflects momentum trading in a volatile sector. Traders should watch intraday support at A$0.010 and resistance near the year high of A$0.020. With a Meyka AI rating of 64.90 (Grade B), the stock is rated HOLD amid high volatility and thin order books typical of small-cap biotechs on the Australian Securities Exchange (ASX).
Go toTop